Selected research
Industry Research
Asthma Medication Industry Research Report 2026
Market perspective
The global Asthma Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Asthma Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Asthma Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Asthma Medication include Merck & Co. Inc, Roche Holdings Ltd, Glaxosmithkline plc, AstraZeneca plc, Theravance Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis and QVAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Asthma Medication market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Asthma Medication Market by Company
Merck & Co. Inc
Roche Holdings Ltd
Glaxosmithkline plc
AstraZeneca plc
Theravance Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
QVAR
MAP Pharmaceuticals，Inc
Genentech Inc
Dulera
Asthma Medication Segment by Type
Asthma Medications During Pregnancy
Quick-Relief Medications
Long-Term Control Medications
Asthma Medication Segment by Application
Children
Adolescent
Adult
Asthma Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Asthma Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Asthma Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Asthma Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Asthma Medications During Pregnancy
- Quick-Relief Medications
- Long-Term Control Medications
Applications
- Children
- Adolescent
- Adult
Companies covered
- Merck & Co. Inc
- Roche Holdings Ltd
- Glaxosmithkline plc
- AstraZeneca plc
- Theravance Inc
- Sepracor, Inc
- Schering-Plough Corp
- Sanofi-Aventis
- QVAR
- MAP Pharmaceuticals，Inc
- Genentech Inc
- Dulera
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Asthma Medication Market Size (2021-2032)
- 2.2.2 Global Asthma Medication Sales (2021-2032)
- 2.2.3 Global Asthma Medication Market Average Price (2021-2032)
- 2.3 Asthma Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Asthma Medications During Pregnancy
- 2.3.3 Quick-Relief Medications
- 2.3.4 Long-Term Control Medications
- 2.4 Asthma Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Children
- 2.4.3 Adolescent
- 2.4.4 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Asthma Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Asthma Medication Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Asthma Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Asthma Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Asthma Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Asthma Medication, Product Type & Application
- 3.8 Global Manufacturers of Asthma Medication, Established Date
- 3.9 Global Asthma Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck & Co. Inc
- 4.1.1 Merck & Co. Inc Company Information
- 4.1.2 Merck & Co. Inc Business Overview
- 4.1.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck & Co. Inc Asthma Medication Product Portfolio
- 4.1.5 Merck & Co. Inc Recent Developments
- 4.2 Roche Holdings Ltd
- 4.2.1 Roche Holdings Ltd Company Information
- 4.2.2 Roche Holdings Ltd Business Overview
- 4.2.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Holdings Ltd Asthma Medication Product Portfolio
- 4.2.5 Roche Holdings Ltd Recent Developments
- 4.3 Glaxosmithkline plc
- 4.3.1 Glaxosmithkline plc Company Information
- 4.3.2 Glaxosmithkline plc Business Overview
- 4.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
- 4.3.5 Glaxosmithkline plc Recent Developments
- 4.4 AstraZeneca plc
- 4.4.1 AstraZeneca plc Company Information
- 4.4.2 AstraZeneca plc Business Overview
- 4.4.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca plc Asthma Medication Product Portfolio
- 4.4.5 AstraZeneca plc Recent Developments
- 4.5 Theravance Inc
- 4.5.1 Theravance Inc Company Information
- 4.5.2 Theravance Inc Business Overview
- 4.5.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Theravance Inc Asthma Medication Product Portfolio
- 4.5.5 Theravance Inc Recent Developments
- 4.6 Sepracor, Inc
- 4.6.1 Sepracor, Inc Company Information
- 4.6.2 Sepracor, Inc Business Overview
- 4.6.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sepracor, Inc Asthma Medication Product Portfolio
- 4.6.5 Sepracor, Inc Recent Developments
- 4.7 Schering-Plough Corp
- 4.7.1 Schering-Plough Corp Company Information
- 4.7.2 Schering-Plough Corp Business Overview
- 4.7.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Schering-Plough Corp Asthma Medication Product Portfolio
- 4.7.5 Schering-Plough Corp Recent Developments
- 4.8 Sanofi-Aventis
- 4.8.1 Sanofi-Aventis Company Information
- 4.8.2 Sanofi-Aventis Business Overview
- 4.8.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sanofi-Aventis Asthma Medication Product Portfolio
- 4.8.5 Sanofi-Aventis Recent Developments
- 4.9 QVAR
- 4.9.1 QVAR Company Information
- 4.9.2 QVAR Business Overview
- 4.9.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 QVAR Asthma Medication Product Portfolio
- 4.9.5 QVAR Recent Developments
- 4.10 MAP Pharmaceuticals，Inc
- 4.10.1 MAP Pharmaceuticals，Inc Company Information
- 4.10.2 MAP Pharmaceuticals，Inc Business Overview
- 4.10.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio
- 4.10.5 MAP Pharmaceuticals，Inc Recent Developments
- 4.11 Genentech Inc
- 4.11.1 Genentech Inc Company Information
- 4.11.2 Genentech Inc Business Overview
- 4.11.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Genentech Inc Asthma Medication Product Portfolio
- 4.11.5 Genentech Inc Recent Developments
- 4.12 Dulera
- 4.12.1 Dulera Company Information
- 4.12.2 Dulera Business Overview
- 4.12.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dulera Asthma Medication Product Portfolio
- 4.12.5 Dulera Recent Developments
5 Global Asthma Medication Market Scenario by Region
- 5.1 Global Asthma Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Asthma Medication Sales by Region: 2021-2032
- 5.2.1 Global Asthma Medication Sales by Region: 2021-2026
- 5.2.2 Global Asthma Medication Sales by Region: 2027-2032
- 5.3 Global Asthma Medication Revenue by Region: 2021-2032
- 5.3.1 Global Asthma Medication Revenue by Region: 2021-2026
- 5.3.2 Global Asthma Medication Revenue by Region: 2027-2032
- 5.4 North America Asthma Medication Market Facts & Figures by Country
- 5.4.1 North America Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Asthma Medication Sales by Country (2021-2032)
- 5.4.3 North America Asthma Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Asthma Medication Market Facts & Figures by Country
- 5.5.1 Europe Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Asthma Medication Sales by Country (2021-2032)
- 5.5.3 Europe Asthma Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Asthma Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Asthma Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Asthma Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Asthma Medication Market Facts & Figures by Country
- 5.7.1 South America Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Asthma Medication Sales by Country (2021-2032)
- 5.7.3 South America Asthma Medication Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Asthma Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Asthma Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Asthma Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Asthma Medication Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Asthma Medication Sales by Type (2021-2032)
- 6.1.1 Global Asthma Medication Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Asthma Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Asthma Medication Revenue by Type (2021-2032)
- 6.2.1 Global Asthma Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Asthma Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Asthma Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Asthma Medication Sales by Application (2021-2032)
- 7.1.1 Global Asthma Medication Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Asthma Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Asthma Medication Revenue by Application (2021-2032)
- 7.2.1 Global Asthma Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Asthma Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Asthma Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Asthma Medication Value Chain Analysis
- 8.1.1 Asthma Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Asthma Medication Production Mode & Process
- 8.2 Asthma Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Asthma Medication Distributors
- 8.2.3 Asthma Medication Customers
9 Global Asthma Medication Analyzing Market Dynamics
- 9.1 Asthma Medication Industry Trends
- 9.2 Asthma Medication Industry Drivers
- 9.3 Asthma Medication Industry Opportunities and Challenges
- 9.4 Asthma Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst